Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL
Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov, Grigorii Nos, Maria Sorokina, Vladislav Maksimov, Andrea Sboner, Michael Sigouros, Koen van Besien, Steven Horwitz, Sarah C. Rutherford, Erin Mulvey, Maria V. Revuelta, Jenny Xiang, Alicia Alonso, Ari Melnick, Olivier ElementoGiorgio Inghirami, John P. Leonard, Leandro Cerchietti, Peter Martin
Dive into the research topics of 'Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL'. Together they form a unique fingerprint.